Breast Cancer in Canadian Women

被引:1
|
作者
Heather Bryant
机构
[1] Division of Population Health and Information, Alberta Cancer Board, Calgary
基金
英国医学研究理事会;
关键词
Breast Cancer; Breast Cancer Risk; Mammographic Screening; Raloxifene; Tamoxifen;
D O I
10.1186/1472-6874-4-S1-S12
中图分类号
学科分类号
摘要
Health issue: Although lung cancer is the leading cause of cancer deaths for Canadian women, breast cancer is the most frequently diagnosed. About 5400 women are expected to die from this disease in 2003. In 1998, a woman's lifetime risk of breast cancer was about one in nine. Key findings: A number of risk factors for breast cancer have been identified. These include advancing age, hormonal factors (eg. early menarche, late menopause and late age at first full-term pregnancy), familial risk, BRCA-1 and BRCA-2 gene mutations, diet and postmenopausal obesity. Several interventions have been introduced to assist women at high risk for breast cancer, including genetic counseling and testing for women who have strong family histories of breast cancer; selective estrogen receptor modifiers, such as tamoxifen, that has been shown to reduce breast cancer rates; prophylactic mastectomy and screening. Data gaps and recommendations: Guidelines are unclear in several areas, particularly in screening. Where clinical guidelines are available, health services research or ongoing monitoring (by provincial/territorial cancer agencies) is needed to assess compliance with the guidelines and to ensure equity of access within the provinces/territories. Key components of organized screening programs need to be established, in part to ensure that screening is carried out in high-quality, co-ordinated programs. There is also a need to develop ways to involve women fully in informed decision-making and to address several policy issues to prevent disparities in access to high-quality services. Patenting issues associated with genetic tests also need to be clarified. © Bryant; licensee BioMed Central Ltd 2004. This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
引用
收藏
相关论文
共 50 条
  • [21] Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention
    Ziv, Elad
    Tice, Jeffrey A.
    Sprague, Brian
    Vachon, Celine M.
    Cummings, Steven R.
    Kerlikowske, Karla
    PLOS ONE, 2017, 12 (01):
  • [22] Hormonotherapy for breast cancer prevention: What about women with genetic predisposition to breast cancer?
    Senechal, Claire
    Reyal, Fabien
    Callet, Nasrine
    This, Pascale
    Nogues, Catherine
    Stoppa-Lyonnet, Dominique
    Fourme, Emmanuelle
    BULLETIN DU CANCER, 2016, 103 (03) : 273 - 281
  • [23] The contribution of founder mutations to early-onset breast cancer in French-Canadian women
    Ghadirian, P.
    Robidoux, A.
    Zhang, P.
    Royer, R.
    Akbari, M.
    Zhang, S.
    Fafard, E.
    Costa, M.
    Martin, G.
    Potvin, C.
    Patocskai, E.
    Larouche, N.
    Younan, R.
    Nassif, E.
    Giroux, S.
    Narod, S. A.
    Rousseau, F.
    Foulkes, W. D.
    CLINICAL GENETICS, 2009, 76 (05) : 421 - 426
  • [24] Dying to Learn: A Scoping Review of Breast and Cervical Cancer Studies Focusing on Black Canadian Women
    Nnorom, Onye
    Findlay, Nicole
    Lee-Foon, Nakia K.
    Jain, Ankur A.
    Ziegler, Carolyn P.
    Scott, Fran E.
    Rodney, Patricia
    Lofters, Aisha K.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2019, 30 (04) : 1331 - 1359
  • [25] Choices in Surgery for Older Women with Breast Cancer
    Swaminathan, Vikram
    Spiliopoulos, Markos K.
    Audisio, Riccardo A.
    BREAST CARE, 2012, 7 (06) : 445 - 451
  • [26] Tamoxifen for women at high risk of breast cancer
    Nazarali, Safia A.
    Narod, Steven A.
    BREAST CANCER-TARGETS AND THERAPY, 2014, 6 : 29 - 36
  • [27] Neoadjuvant endocrine treatment of women with breast cancer
    Iturbe, Julian
    Leone, Jose Pablo
    Zwenger, Ariel
    Vallejo, Carlos
    Leone, Bernardo
    ONCOLOGY REVIEWS, 2011, 5 (03) : 157 - 166
  • [28] Special Issues in Older Women with Breast Cancer
    Hurria, Arti
    Muss, Hy
    IMPROVING OUTCOMES FOR BREAST CANCER SURVIVORS: PERSPECTIVES ON RESEARCH CHALLENGES AND OPPORTUNITIES, 2015, 862 : 23 - 37
  • [29] Tamoxifen in women with breast cancer and mammographic density
    Meggiorini, M. L.
    Labi, L.
    Vestri, A. R.
    Porfiri, L. M.
    Savelli, S.
    De Felice, C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2008, 29 (06) : 598 - 601
  • [30] Issues with Fertility in Young Women with Breast Cancer
    Christian, Nicole
    Gemignani, Mary L.
    CURRENT ONCOLOGY REPORTS, 2019, 21 (07)